180 Life Sciences Corp (ATNF NASDAQ) stock market data APIs
$2.516
-0.18(-7.2%)
as of September 18, 2025
Try our APIs with
free plan!
180 Life Sciences Corp Financial Data Overview
Price chart is built with
Anychart
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain. 180 Life Sciences Corp. is headquartered in Palo Alto, California.
Prev. Close
2.516
Open
2.3386
High
2.5307
Low
2.3207
52 wk Range
0.658-12.74
Market Cap
1 077 M
Shares Outstanding
153 M
EPS
-0.3
Beta
0.406
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 180 Life Sciences Corp data using free add-ons & libraries
Get 180 Life Sciences Corp Fundamental Data
180 Life Sciences Corp Fundamental data includes:
- Net Revenue:
- EBITDA: -6 449 047
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-23
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
180 Life Sciences Corp News
New
Forward Industries Stock Doubles as Firm Pivots to Being Solana Treasury
Thomas Fuller / SOPA Images / LightRocket via Getty Images Forward Industries will shift its business into a cryptocurrency treasury focused on Solana Key Takeaways Forward Industries will shift its...
Ethereum Treasury ETHZilla Reveals $250 Million Buyback After Stock Craters
ETHZilla Corporation—a publicly traded Ethereum treasury firm formerly known as 180 Life Sciences—announced Monday that its board has authorized a stock repurchase program of up to $250 million of...
New Ether Treasury ETHZilla Stock Jumps on Buyback Program
Thomas Fuller / SOPA Images / LightRocket via Getty Images The company formerly known as 180 Life Sciences recently shifted its focus to building a treasury of the Ether cryptocurrency Key Takeaways ...
Biotechs Turn to Digital Coins, Crypto to Boost Stock Prices
(Bloomberg) -- They’re supposed to be on the cutting edge of medicine. Yet some tiny biotech companies, largely left behind in the stock market’s breakneck rally, are pursuing a new cure-all: Cryp...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
